Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Eusebi

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|October 19, 2013
Diagnostic accuracy measuresPaolo Eusebi
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial EnrichmentLucilla Parnetti, Paolo Eusebi
Journal of Applied Measurement|January 7, 2015
Differential item functioning analysis by applying multiple comparison proceduresPaolo Eusebi, Svend Kreiner
Journal of Medical Virology|August 10, 2020
Bayesian latent class models to estimate diagnostic test accuracies of COVID-19 testsSonja Hartnack, Paolo Eusebi, Polychronis Kostoulas
Psychiatria Danubina|November 22, 2014
Psychiatry in the emergency room: one year period of clinical experienceSerena Anastasi, Paolo Eusebi, Roberto Quartesan
Plos One|July 28, 2022
Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infectionGeorge Balaouras, Paolo Eusebi, Polychronis Kostoulas
American Journal of Epidemiology|April 6, 2021
Diagnostic Accuracy Estimates for COVID-19 Real-Time Polymerase Chain Reaction and Lateral Flow Immunoassay Tests With Bayesian Latent-Class ModelsPolychronis Kostoulas, Paolo Eusebi, Sonja Hartnack
Frontiers of Neurology and Neuroscience|July 28, 2016
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's DiseasesLucilla Parnetti, Paolo Eusebi, Alberto Lleó
Psychiatria Danubina|November 22, 2014
Psychiatry in the emergency room: clinical experience in PerugiaSerena Anastasi, Paolo Eusebi, Roberto Quartesan
Biomarkers in Medicine|December 9, 2015
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisLucilla Parnetti, Claudia Cicognola, Paolo Eusebi, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Cerebrovascular Diseases (Basel, Switzerland)|October 19, 2013
Diagnostic accuracy measuresPaolo Eusebi
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial EnrichmentLucilla Parnetti, Paolo Eusebi
Journal of Applied Measurement|January 7, 2015
Differential item functioning analysis by applying multiple comparison proceduresPaolo Eusebi, Svend Kreiner
Journal of Medical Virology|August 10, 2020
Bayesian latent class models to estimate diagnostic test accuracies of COVID-19 testsSonja Hartnack, Paolo Eusebi, Polychronis Kostoulas
Psychiatria Danubina|November 22, 2014
Psychiatry in the emergency room: one year period of clinical experienceSerena Anastasi, Paolo Eusebi, Roberto Quartesan
Plos One|July 28, 2022
Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infectionGeorge Balaouras, Paolo Eusebi, Polychronis Kostoulas
American Journal of Epidemiology|April 6, 2021
Diagnostic Accuracy Estimates for COVID-19 Real-Time Polymerase Chain Reaction and Lateral Flow Immunoassay Tests With Bayesian Latent-Class ModelsPolychronis Kostoulas, Paolo Eusebi, Sonja Hartnack
Frontiers of Neurology and Neuroscience|July 28, 2016
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's DiseasesLucilla Parnetti, Paolo Eusebi, Alberto Lleó
Psychiatria Danubina|November 22, 2014
Psychiatry in the emergency room: clinical experience in PerugiaSerena Anastasi, Paolo Eusebi, Roberto Quartesan
Biomarkers in Medicine|December 9, 2015
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisLucilla Parnetti, Claudia Cicognola, Paolo Eusebi, et al.
Pageof 13